Sections
Shows
Events
Cipla inks licensing pact with Gilead Sciences for potential COVID-19 treatment drug remdesivir
Hetero inks licensing agreement with Gilead for manufacturing, distribution of remdesivir
Gilead ties up with 5 generic drugmakers in India, Pakistan for COVID-19 drug supply; licensees to set price for product
